GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Price-to-Owner-Earnings

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Price-to-Owner-Earnings

: (As of Today)
View and export this data going back to 2021. Start your Free Trial

As of today (2024-04-18), Regencell Bioscience Holdings's share price is $5.22. Regencell Bioscience Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Regencell Bioscience Holdings's Price-to-Owner-Earnings or its related term are showing as below:


RGC's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 26.9
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-18), Regencell Bioscience Holdings's share price is $5.22. Regencell Bioscience Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.45. Therefore, Regencell Bioscience Holdings's PE Ratio for today is At Loss.

As of today (2024-04-18), Regencell Bioscience Holdings's share price is $5.22. Regencell Bioscience Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.45. Therefore, Regencell Bioscience Holdings's PE Ratio without NRI for today is At Loss.


Regencell Bioscience Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for Regencell Bioscience Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Owner-Earnings
- - - - -

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regencell Bioscience Holdings Price-to-Owner-Earnings Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's Price-to-Owner-Earnings falls into.



Regencell Bioscience Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Regencell Bioscience Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=5.22/-0.46
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Regencell Bioscience Holdings  (NAS:RGC) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Regencell Bioscience Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus